Cyclacel Pharmaceuticals Inc [NASDAQ: CYCC] surged by $0.01 during the normal trading session on while it closed the day at $0.35.
Cyclacel Pharmaceuticals Inc stock has also gained 25.68% of its value over the past 7 days. However, CYCC stock has declined by -92.78% in the 3 months of the year. Over the past six months meanwhile, it has lost -94.02% and lost -94.18% year-on date.
The market cap for CYCC stock reached $7.80 million, with 22.27 million shares outstanding and 22.27 million shares in the current float. Compared to the average trading volume of 993.04K shares, CYCC reached a trading volume of 17265175 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Cyclacel Pharmaceuticals Inc [CYCC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CYCC shares is $16.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CYCC stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Cyclacel Pharmaceuticals Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 18, 2022. While these analysts kept the previous recommendation, ROTH Capital raised their target price to Buy. The new note on the price target was released on April 27, 2020, representing the official price target for Cyclacel Pharmaceuticals Inc stock.
The Average True Range (ATR) for Cyclacel Pharmaceuticals Inc is set at 0.34, with the Price to Sales ratio for CYCC stock in the period of the last 12 months amounting to 779.92. The Price to Book ratio for the last quarter was 1.48, with the Price to Cash per share for the same quarter was set at 0.15.
CYCC stock trade performance evaluation
Cyclacel Pharmaceuticals Inc [CYCC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.68. With this latest performance, CYCC shares dropped by -82.48% in over the last four-week period, additionally sinking by -94.02% over the last 6 months – not to mention a drop of -98.67% in the past year of trading.
#####
Cyclacel Pharmaceuticals Inc [CYCC]: An insightful look at the core fundamentals
Cyclacel Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.60 and a Current Ratio set at 5.60.
